MRNA

Moderna, Inc.

Halal Rating :
Comfortable
Last Price $35.50 Last updated:
Market Cap $29.75b
7D Change 1.0%
1 Year Change -64.39%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Biological Products
  • Except Diagnostic Substances
Exchange NASDAQ
Next Earnings Date Oct. 31, 2024

Moderna, Inc. is a biotechnology company focused on developing messenger RNA (mRNA) therapeutics and vaccines. The company gained global recognition for developing one of the first COVID-19 vaccines. Beyond COVID-19, Moderna is developing mRNA-based treatments for various diseases including cancer, cardiovascular conditions, and rare genetic disorders.

The company's main revenue streams come from vaccine sales and partnerships with other pharmaceutical companies for research and development. Their business model is based on developing innovative medical solutions using their mRNA technology platform.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $1.86b $1.93b - - 0.00% 0.00%
June 30, 2024 $241.0m $1.6b - - 0.00% 0.00%
March 31, 2024 $167.0m $1.43b - - 0.00% 0.00%

Company Impact

Help us evaluate Moderna, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Recent News & Updates